BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

Abstract Vaccination against an airborne pathogen is very effective if it induces also the development of mucosal antibodies that can protect against infection. The mRNA‐based vaccine‐encoding SARS‐CoV‐2 full‐length spike protein (BNT162b2, Pfizer/BioNTech) protects also against infection despite be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Abbass Darwich, Chiara Pozzi, Giulia Fornasa, Michela Lizier, Elena Azzolini, Ilaria Spadoni, Francesco Carli, Antonio Voza, Antonio Desai, Carlo Ferrero, Luca Germagnoli, ICH COVID‐19 Task‐force, Alberto Mantovani, Maria Rescigno
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2022-05-01
Colecção:EMBO Molecular Medicine
Assuntos:
BNT162b2
IgA
IgG
mucosal immunity
SARS‐CoV‐2
Acesso em linha:https://doi.org/10.15252/emmm.202115326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados